Skip to main content
Have a personal or library account? Click to login
Does dehydroepiandrosterone sulfate have a role in COVID-19 prognosis and treatment? Cover

Does dehydroepiandrosterone sulfate have a role in COVID-19 prognosis and treatment?

Endocrine Regulations
Volume 55 (2021): Issue 3 (July 2021)
By: ,  ,   and    
Open Access
|Sep 2021
Articles in this issue
DOI: https://doi.org/10.2478/enr-2021-0019 | Journal eISSN: 1336-0329 | Journal ISSN: 1210-0668
Journal RSS Feed
Language: English
Page range: 174 - 181
Published on: Sep 13, 2021
Published by: Slovak Academy of Sciences, Institute of Experimental Endocrinology
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
COVID-19,
hypothalamic-pituitary-adrenal axis,
DHEA,
DHEAS,
cortisol
Related subjects:
Life sciences,
Molecular biology,
Neurobiology,
Medicine,
Basic medical science,
Basic medical science, other,
Clinical medicine,
Internal medicine,
Endocrinology, diabetology

© 2021 Sojit Tomo, Mithu Banerjee, Praveen Sharma, Mahendra Garg, published by Slovak Academy of Sciences, Institute of Experimental Endocrinology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 55 (2021): Issue 3 (July 2021)
Previous article
Next article